Specific neurologic complications of human immunodeficiency virus type 1 (HIV-1) infection in children

Journal of Child Neurology

Volumn 21, Issue 9, 2006, Pages 788-794

  Wilmshurst, Jo M ^a   Burgess, John ^a   Hartley, Patricia ^a   Eley, Brian ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ARTICLE; BLINDNESS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FAHR DISEASE; FEMALE; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRACTABLE EPILEPSY; LYMPHOMA; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SPINAL CORD DISEASE; SPINAL CORD TUMOR; SURVIVAL TIME; VASCULITIS;

BURKITT LYMPHOMA; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CEREBROVASCULAR DISORDERS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; SOUTH AFRICA; SPINAL CORD NEOPLASMS;

EID: 33750711414     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210091901     Document Type: Article

References (38)

1. Lobato MN, Cladwell MB, Ng P, Oxtoby MJ, and the Pediatric Spectrum of Disease Clinical Consortium: Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. J Pediatr 1995;126:710-715.
2. Cooper ER, Hanson C, Diaz C, et al: Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired immunodeficiency virus infection. J Pediatr 1998;132:808-812.
3. Brouwers P, Wolters P, Civitello L: Central nervous system manifestations and assessement, in Pizzo PA, Wilfert CM (eds): Paediatric AIDS. The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Lippincott Williams and Wilkins, 1998, 293-308.
4. Mintz M: Neurological abnormalities, in Yogev R, Connor E (eds): Management of HIV in Infants and Children. St Louis, Mosby Year Book, 1992, 247-285.
5. Pillay K, Colvin M, Williams R, Coovardia HM: Impact of HIV-1 infection in South Africa. Arch Dis Child 2001;85:50-51.
6. Dorrington RE: How many people are currently infected with HIV in South Africa? S Afr Med J 2002;92:196-197.
7. Englund JA, Baker CJ, Raskino C, et al: Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. Pediatr Infect Dis J 1996;15:1025-1036.
8. Butler KM, Husson RN, Balis FM, et al: Dideoxyinosine in children with symptomatic human virus infection. N Engl J Med 1991;324:137-144.
9. Civitello LA, Brouwers P, Pizzo PA: Neurological and neuropsychological manifestations in 120 children with symptomatic human immunodeficiency virus infection, abstract. Ann Neurol 1993;34:481.
10. Burns DK: The neuropathology of pediatric acquired immunodeficiency syndrome. J Child Neurol 1992;7:332-346.
11. Meeker RB, Boles JC, Bragg DC, et al: Development of neuronal sensitivity to toxins in cerebrospinal fluid from HIV-type 1-infected individuals. AIDS Res Hum Retroviruses 2004;20:1072-1086.
12. Speth C, Dierich MP, Sopper S: HIV-infection of the central nervous system: The tightrope walk of innate immunity. Molec Immunol 2005;42:213-228.
13. Berger JR, Scott G, Albrecht J, et al: Progressive multifocal Leukoencephalopathy in HIV-1-infected children. AIDS 1992;6: 837-841.
14. Johnson RT: The virology of demyelinating diseases. Ann Neurol 1994;(Suppl 36):S54-S60.
15. Sweet TM, Valle LD, Khalili K: Molecular biology and immunoregulation of human neurotropic JC virus in CNS. J Cell Physiol 2002;191:249-256.
16. Darin N, Bergstrom T, Fast A, Kyllerman M: Clinical, serological and PCR evidence of cytomegalovirus infection in the central nervous system in infancy and childhood. Neuropediatrics 1994; 25:316-322.
17. Epstein LG, Sharer LR, Oleske JM, et al: Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 1986;78:678-687.
18. Bremon-Gignac D, Aron-Rosan D, Rohrlich P, et al: Cytomegalovirus retinitis in children with AIDS acquired through materno-fetal transmission. J Fr Ophthalmol 1995;18:91-95.
19. Dickson DW, Llena JF, Wiedenheim KM, et al: Central nervous system pathology in children with AIDS and focal neurological signs: Stroke and lymphoma, in Kozlowski PB, Snider DA, Vietze PM, Wisniewski HM (eds): Brain in Pediatric AIDS. Basel, Karger, 1990, 147-157.
20. Shah SS, Zimmerman RA, Rorke LB, Vezina LG: Cerebrovascular complications of HIV in children. AJNR Am J Neuroradiol 1996; 17:1913-1917.
21. Park YD, Belman AL, Kim T-S, et al: Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 1990;28:303-311.
22. Mintz M, Epstein LG, Koenigsberger MR: Neurological manifestations of acquired immunodeficiency syndrome in children. Int Pediatr 1989;4:161-171.
23. Epstein LG, DiCarlo FJ, Joshi VV, et al: Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome. Pediatrics 1988;82:355-363.
24. Murray JM, Morgello S: Polyomaviruses and primary central nervous system lymphomas. Neurology 2004;63:1299-1301.
25. Agius LM: Viral participation in cellular and microenvironmental transformation and amplification towards malignancy in AIDS patients. Med Hypotheses 2004;62:593-599.
26. Petito CK, Navia BA, Cho E-S, et al: Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312:874-879.
27. Dickson DW, Belman AL, Horoupian DS, Rubinstein A: Spinal cord pathology in pediatric acquired immunodeficiency syndrome. Neurology 1989;39:227-235.
28. Bhigjee AI, Madurai S, Bill PLA, et al: Spectrum of myelopathies in HIV seropositive South African patients. Neurology 2001;57: 348-351.
29. Vema A: Epidemiology and clinical features of H1V-1 associated neuropathies. J Periph Nerv Syst 2001;6:8-13.
30. Dalakas MC: Myopathies and neuropathies in HIV-infected adults and children, in Pizzo PA, Wilfert CM (eds): Paediatric AIDS. The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Lippincott Williams and Wilkins, 1998, 403-415.
31. Floeter MK, Civitello LA, Everett CR, et al: Peripheral neuropathy in children with HIV infection. Neurology 1997;49:207-212.
32. Raphael SA, Price ML, Lischner HW, et al: Inflammatory demyelinating polyneuropathy in a child with symptomatic human immunodeficiency virus infection. J Pediatr 1991;118: 242-245.
33. So YT, Holtzman DM, Abrams DI, Olney RK: Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol 1988;45:945-948.
34. Keswani SC, Policy M, Pardo CA, et al: Schwann cell chemokine receptors mediate HIV-1 gp-120 toxicity to sensory neurones. Ann Neurol 2003;54:287-296.
35. Umehara H, Bloom ET, Okazaki T, et al: Fractalkine in vascular biology: From basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004;24:34-40.
36. Ghilardi G, Biondi ML, Turri O, et al: Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: A genetic risk factor. Stroke 2004;35:1276-1279.
37. Su ZZ, Leszczyniecka M, Kang DC, et al: Insights into glutamate transporter regulation in human astrocytes: Cloning of the promotor for excitatory amino acid transporter 2 (EAAT2). Proc Natl Acad Sci U S A 2003;100:1955-1960.
38. Boya P, Paulen A-L, Poncet D, et al: Viral proteins targeting mitochondria: Controlling cell death. Biochim Biophys Acta 2004;1659:178-189.